Cargando…

Updates in Diagnosis and Treatment of Acromegaly

Acromegaly is a rare disease, caused largely by a growth hormone (GH) pituitary adenoma. Incidence is higher than previously thought. Due to increased morbidity and mortality, if not appropriately treated, early diagnosis efforts are essential. Screening is recommended for all patients with clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Zahr, Roula, Fleseriu, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Touch Medical Media 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182922/
https://www.ncbi.nlm.nih.gov/pubmed/30349595
http://dx.doi.org/10.17925/EE.2018.14.2.57
_version_ 1783362668795527168
author Zahr, Roula
Fleseriu, Maria
author_facet Zahr, Roula
Fleseriu, Maria
author_sort Zahr, Roula
collection PubMed
description Acromegaly is a rare disease, caused largely by a growth hormone (GH) pituitary adenoma. Incidence is higher than previously thought. Due to increased morbidity and mortality, if not appropriately treated, early diagnosis efforts are essential. Screening is recommended for all patients with clinical features of GH excess. There is increased knowledge that classical diagnostic criteria no longer apply to all, and some patients can have GH excess with normal GH response to glucose. Treatment is multifactorial and personalised therapy is advised.
format Online
Article
Text
id pubmed-6182922
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Touch Medical Media
record_format MEDLINE/PubMed
spelling pubmed-61829222018-10-22 Updates in Diagnosis and Treatment of Acromegaly Zahr, Roula Fleseriu, Maria Eur Endocrinol Pituitary Acromegaly is a rare disease, caused largely by a growth hormone (GH) pituitary adenoma. Incidence is higher than previously thought. Due to increased morbidity and mortality, if not appropriately treated, early diagnosis efforts are essential. Screening is recommended for all patients with clinical features of GH excess. There is increased knowledge that classical diagnostic criteria no longer apply to all, and some patients can have GH excess with normal GH response to glucose. Treatment is multifactorial and personalised therapy is advised. Touch Medical Media 2018-09 2018-09-10 /pmc/articles/PMC6182922/ /pubmed/30349595 http://dx.doi.org/10.17925/EE.2018.14.2.57 Text en © The Author(s) 2018 http://creativecommons.org/licenses/by-nc/3.0/ This article is published under the Creative Commons Attribution Noncommercial License, which permits any non-commercial use, distribution, adaptation and reproduction provided the original author(s) and source are given appropriate credit. © The Authors 2018. Review Process: Double-blind peer review Authorship: All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship of this manuscript, take responsibility for the integrity of the work as a whole, and have given final approval to the version to be published.
spellingShingle Pituitary
Zahr, Roula
Fleseriu, Maria
Updates in Diagnosis and Treatment of Acromegaly
title Updates in Diagnosis and Treatment of Acromegaly
title_full Updates in Diagnosis and Treatment of Acromegaly
title_fullStr Updates in Diagnosis and Treatment of Acromegaly
title_full_unstemmed Updates in Diagnosis and Treatment of Acromegaly
title_short Updates in Diagnosis and Treatment of Acromegaly
title_sort updates in diagnosis and treatment of acromegaly
topic Pituitary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182922/
https://www.ncbi.nlm.nih.gov/pubmed/30349595
http://dx.doi.org/10.17925/EE.2018.14.2.57
work_keys_str_mv AT zahrroula updatesindiagnosisandtreatmentofacromegaly
AT fleseriumaria updatesindiagnosisandtreatmentofacromegaly